Implantable medical device developer Tepha said today it completed a buy-out of its roylaty obligations with former licensor and parent company Metabolix.
Get the rest of the story at our sister site, Medical Design & Outsourcing
The post Tepha closes royalty rights buyout from Metabolix appeared first on MassDevice.
from MassDevice http://ift.tt/2daSjl4
Cap comentari:
Publica un comentari a l'entrada